(ENTA) Enanta Pharmaceuticals Weekly charts technical analysis
(ENTA) Enanta Pharmaceuticals Weekly charts technical analysis Weekly analysis of Enanta Pharmaceuticals | Buy/Sell Enanta Pharmaceuticals
Enanta Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Enanta Pharmaceuticals is 439830
| Date | Closing Price | Open | High | Low | Volume |
| 30 Thu Jan 2025 | 5.14 | 5.50 | 5.76 | 4.94 | 0.93 Mn |
| 24 Fri Jan 2025 | 5.53 | 5.30 | 5.72 | 4.96 | 1.571 Mn |
| 17 Fri Jan 2025 | 5.25 | 4.87 | 5.31 | 4.83 | 0.694 Mn |
| 17 Fri Jan 2025 | 5.25 | 4.96 | 5.31 | 4.71 | 3.552 Mn |
| 10 Fri Jan 2025 | 5.09 | 5.39 | 5.39 | 4.87 | 1.801 Mn |
| 08 Wed Jan 2025 | 5.16 | 5.65 | 5.73 | 5.11 | 2.369 Mn |
| 03 Fri Jan 2025 | 5.58 | 5.93 | 6.10 | 5.30 | 4.333 Mn |
| 27 Fri Dec 2024 | 6.01 | 6.28 | 6.45 | 5.73 | 1.263 Mn |
| 20 Fri Dec 2024 | 6.28 | 6.00 | 6.56 | 5.70 | 2.562 Mn |
| 13 Fri Dec 2024 | 6.05 | 8.12 | 9.46 | 6.02 | 3.738 Mn |
Indicators analysis of Enanta Pharmaceuticals (ENTA)
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Enanta Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Enanta Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Enanta Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Enanta Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Enanta Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.59 and Enanta Pharmaceuticals (ENTA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Enanta Pharmaceuticals (ENTA) stock. Volume based technical analysis of Enanta Pharmaceuticals (ENTA) stock is negative.
Enanta Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Weekly charts
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Enanta Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Enanta Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Enanta Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Enanta Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Enanta Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.59 and Enanta Pharmaceuticals (ENTA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Enanta Pharmaceuticals (ENTA) stock. Volume based technical analysis of Enanta Pharmaceuticals (ENTA) stock is negative.
Enanta Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.